Kentucky Injury Lawyers

Makers of Xarelto Sued for Internal Bleeding

Published on Oct 14, 2014 at 1:56 pm in Dangerous Drugs.

Liable Drug ManufacturersLawsuits have been filed in state and federal court by plaintiffs who suffered serious internal bleeding after taking Xarelto. The anti-clotting drug is manufactured by the German drug giant Bayer. Xarelto is distributed in the U.S. by Johnson & Johnson subsidiary Janssen Pharmaceuticals.

Xarelto is a blood thinner. The anti-clotting drug is one of Bayer’s top five medicines and it earned $1.3 billion in sales last year.

The lawsuits charge that the companies failed to warn users that Xarelto could result in irreversible internal bleeding. Xarelto has been marketed as a more convenient choice than warfarin (Coumadin), which is used as an anticoagulant in the U.S. since the 1950s. Warfarin requires patients to take frequent blood tests and follow a strict diet. However, warfarin’s anticoagulation is reversible by administering Vitamin K. Xarelto does not have a known reversal agent and many of the serious bleeding incidents have led to death.

Judge Accuses Takeda of Destroying Actos Evidence

Published on Aug 6, 2014 at 8:41 am in Dangerous Drugs.

Last Spring, a federal jury found that the makers of the diabetes drug Actos knew about and concealed the drug’s cancer risks. The plaintiff in that case was a New York man who claims his bladder cancer was caused by Actos.

The jury awarded the plaintiff $1.5 million in compensatory damages and, additionally, a $9 billion punitive damages award was ordered against the manufacturers. This amounted to $6 billion against Japan-based Takeda Pharmaceuticals and $3 billion against Eli Lilly, which co-marketed the drug.

After the trial, charges have been made that Takeda’s company and its lawyers concealed evidence. In late June, the judge formally admonished Takeda for destroying evidence in the case. A later decision will consider attorney misconduct regarding Takeda’s defense team.

Actos is the brand name of the prescription drug pioglitazone, which was approved by the FDA to treat Type 2 diabetes in 1999. In July 2011, the FDA issued a warning that Actos “may be associated with an increased risk of bladder cancer” after use for more than one year. This came after long-term studies showed not just a cancer link, but a high cancer link – patients who used Actos for more than one year had up to a 40% increased chance of developing cancer.

Why Many Supplements Do Not Work

Published on Jul 22, 2014 at 8:30 am in Dangerous Drugs.

Supplemental Danger DrugsThe U.S. vitamins and minerals supplement industry has boomed over the last 25 years. While the promoted benefits make sense -“Vitamins are good for you and you can’t get them all from food, so supplement!”–the reality is that few studies have ever actually proven any of these benefits.

The June 2014 issue of Consumer Reports: On Health analyzes the latest research on why some supplements work, but so many don’t. We do know that studies have shown that people whose diets include strong levels of certain nutrients have a lower incidence of several diseases. But so far, blind trials giving people supplements versus placebos have not shown to provide the same benefits. There still is not enough evidence to support many of the claimed benefits of supplements and Consumer Reports caution that many vitamins can have negative side effects when taken in high doses.

Testosterone Therapy Lawsuits Consolidated in Chicago

Published on Jul 17, 2014 at 8:30 am in Dangerous Drugs.

Bloomberg News reports a significant number of cases against the makers of testosterone replacement therapy are now being consolidated. Up to 45 lawsuits in four different districts around the country will be centralized and handled by one federal judge in Chicago, with the potential of many more to come.

Abbott and AbbVie, a spin-off from Abbott’s research-based pharmaceutical business, are facing roughly 45 AndroGel cases thus far. After the spin-off, the U.S. commercial rights and responsibilities for AndroGel legally passed to AbbVie, which is based in North Chicago, Illinois.

Consumer Reports: Beware of Supplements

Published on Jul 8, 2014 at 8:30 am in Dangerous Drugs.

Supplemental Danger DrugsThe new issue Consumer Reports: OnHealth newsletter warns consumers to consider whether supplements are really safe. The first major problem with the $28 billion dollar supplement industry is that even though the products are sold on supermarket shelves, health food stores and drug stores, they aren’t really regulated; at least not before they go to market.

The second problem is labeling. A 2013 Consumer Reports survey found that fully 55% of those polled believed that the U.S. government requires supplement makers to include warnings about potential dangers and side effects. It does not.